How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows...
Read More
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner...
Read More
Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider...
Read More
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
Elizabeth Thurgar tells us about her ISPOR poster reviewing fast-track appraisals at NICE and the evolution of cost comparison
The proposed new NHS England (NHSE) systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects of policy...
Read More
The Mtech Access team reflect on a energising and inspiring ISPOR Europe – with commentary from top 10 influencer Prof Phil Richardson
With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can...
Read More
Prof Phil Richardson join Mtech Access as Chair and Chief Innovation Officer. His initial focus will be to bring together the NHS, industry and academia to drive innovation through partnership and collaboration.
